Show simple item record

dc.contributor.authorVekemansa, Marc
dc.contributor.authorJohnb, Laurence
dc.contributor.authorColebunders, Robert
dc.date.accessioned2012-05-28T09:21:11Z
dc.date.available2012-05-28T09:21:11Z
dc.date.issued2007
dc.identifier.citationVekemansa, M.,John, L.,Colebunders, R. (2007). When to switch for antiretroviral treatment failure in resource-limited settings? AIDS, 21en_US
dc.identifier.issn0269-9370
dc.identifier.urihttp://hdl.handle.net/10570/591
dc.description.abstractThanks to the leadership of the World Health Organisation (WHO) [1], and massive financial support from programmes such as the Global Fund and the US President’s Emergency Plan for AIDS Relief (PEPFAR), the number of HIV-infected individuals accessing antiretroviral therapy (ART) in resource-limited settings has tripled from 2001 to 2005. An estimated 1.3 million HIV-infected individuals were on ART in 2005, representing 20% of those in need of treatment [2].en_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkins.en_US
dc.subjectAntiretroviral therapyen_US
dc.subjectHIVen_US
dc.subjectResistanceen_US
dc.subjectSwitchingen_US
dc.subjectVirological failureen_US
dc.subjectCD4+ lymphocyte counten_US
dc.subjectPEPFARen_US
dc.titleWhen to switch for antiretroviral treatment failure in resource-limited settings?en_US
dc.typeJournal article, peer revieweden_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record